Skip to main content

$0.040 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
17 May 2025 at 4:51pm
Register to track AC8 and receive email alerts.
Subject
AC8 Ann: Notice of Annual General Meeting/Proxy Form

AC8 Ann: AusCann Completes US Safety Study for DermaCann Registration

AC8 Ann: AusCann to Accelerate Human Drug Development Program

AC8 Ann: AusCann Appoints US Advisors to Advance CPAT-01 FDA Program

AC8 Ann: Key Company Highlights & Financial Commentary for FY2021

AC8 Ann: Appendix 4E and Annual Financial Statements

AC8 Ann: Appendix 4G and Corporate Governance Statement

AC8 Ann: Notification of cessation of securities - AC8

AC8 Ann: June 2021 Quarterly Activities and Cashflow Reports

AC8 Ann: AusCann Commences Australian Product Registration for Dogs

AC8 Ann: AusCann Successful in Tender with Tasmanian Dept of Health

AC8 Ann: AusCann Enters into Lease Agreement for R&D Facility

AC8 Ann: Change of Director's Interest Notice - G. Starr

AC8 Ann: CPAT-01 Improves Pain, Lameness and Quality of Life in Dogs

AC8 Ann: March 2021 Quarterly Activities and Cashflow Reports

AC8 Ann: AusCann Receives R&D Tax Incentive Refund of $1.6m

AC8 Ann: Chief Executive Officer Terms of Appointment

AC8 Ann: Change of Director's Interest Notice - M. Johnston

AC8 Ann: Initial Director's Interest Notice x 3

AC8 Ann: Presentation - Cannabis & Hemp Investment Conference

AC8 Ann: Change of Director's Interest Notice x 3

AC8 Ann: AusCann Receives US$500k for Sale of Chilean Joint Venture

AC8 Ann: Appendix 2A

AC8 Ann: Appendix 3G

AC8 Ann: CP1: Implementation of Scheme of Arrangement

AC8 Ann: Change in substantial holding

AC8 Ann: Implementation of CannPal Scheme of Arrangement

AC8 Ann: Proposed issue of Securities - AC8

AC8 Ann: CP1: Lodgement of Court Orders with ASIC

AC8 Ann: CP1: Court Approves Scheme of Arrangement

AC8 Ann: Appendix 4D and Half-Year Financial Report 31 December 2020

AC8 Ann: Executive Appointments

AC8 Ann: Completion of Small Shareholding Sale Facility

AC8 Ann: CP1: Scheme of Arrangement Booklet

AC8 Ann: CP1: Registration of Scheme of Arrangement Booklet

AC8 Ann: CP1: Court Orders Scheme of Arrangement

AC8 Ann: December 2020 Quarterly Activities and Cashflow Reports

AC8 Ann: AusCann Leadership Post CannPal Acquisition

AC8 Ann: AusCann Supports Final TGA Decision for Over-the-Counter CBD

AC8 Ann: UN Vote to Reclassify Cannabis-Related Substances

AC8 Ann: Results of Annual General Meeting

AC8 Ann: Annual General Meeting Presentation

AC8 Ann: 2020 Annual General Meeting Chairman's Address

AC8 Ann: AusCann and CannPal Enter into Scheme of Arrangement

AC8 Ann: CannPal and AusCann Enter into Scheme of Arrangement

AC8 Ann: Trading Halt

AC8 Ann: AusCann Enters Sale Agreement for DayaCann JV Interest

AC8 Ann: Medical Advisory Board & Clinical Evaluation Programme

AC8 Ann: AusCann Appoints Advisor, Suspends Small Share Sale Facility

AC8 Ann: September 2020 Quarterly Activities and Cashflow Reports

Register to track AC8 and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL